Prescribing patterns of anti-emetic drugs during pregnancy in Germany

Archives of Gynecology and Obstetrics

Volumn 275, Issue 6, 2007, Pages 461-467

  Markl, Gertraud E ^a   Strunz Lehner, Chirstine ^a   Egen Lappe, Veronika ^a   Hasford, Joerg ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anti emetics; Drug prescription; Nausea; Pregnancy; Risk classification; Vomiting

Indexed keywords

ANTIEMETIC AGENT; CHLORPHENETHAZINE; CISAPRIDE; DEXPANTHENOL; DIMENHYDRINATE; DIPHENHYDRAMINE; DOMPERIDONE; HERBACEOUS AGENT; HOMEOPATHIC AGENT; MECLOZINE; ONDANSETRON; TRIFLUPROMAZINE;

ADOLESCENT; ADULT; ARTICLE; CARAWAY; CLINICAL PRACTICE; COLCHICUM; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MENTHA PIPERITA; NAUSEA; PREGNANCY; PRESCRIPTION; VOMITING;

ADOLESCENT; ADULT; ANTIEMETICS; FEMALE; GERMANY; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY;

EID: 34249047370     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-006-0286-0     Document Type: Article

References (26)

1. American College of Gynecology: Practice Bulletin (2004) Nausea and vomiting in pregnancy. Obstet Gynecol Number 52103(4):803-814
2. Arzneimittelkommission der deutschen Ärzteschaft (2000) http://www.akdae.de/20/40/Archiv/2000/Propulsin.pdf (cited June 03, 2006)
3. Baggley A, Navioz Y, Maltepe C, Koren G, Einarson A (2004) Determinants of women's decision making on whether to treat nausea and vomiting of pregnancy pharmacologically. J Midwifery Womens Health 49(4):350-354
4. Beyens MN, Guy C, Ratrema M, Ollagnier M (2003) Prescription of drugs to pregnant women in France: the HIMAGE Study. Therapie 58(6):505-511
5. Borreli F, Capasso R, Aviello G, Pittler MH, Izzo AA (2005) Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol 105(4):849-856
6. Breyer F, Zweifel PS, Kifmann M (2003) Health economics (Gesundheitsökonomie). Springer, Berlin Heidelberg New York
7. Briggs GG, Freeman RG, Yaffe SJ (2002) Drugs in pregnancy and lactation, 6th edn. Lippincott Williams and Wilkins, Baltimore
8. Buttino L Jr, Coleman SK, Bergauer NK, Gambon C, Stanziano GJ (2000) Home subcutaneous metoclopramide therapy for hyperemesis gravidarum. J Perinatol 20(6):359-362
9. De Jong-van den Berg LT, van den Berg PB, Haaijer-Ruskamp FM, Dukes MN, Wesseling H (1991) Investigating drug use in pregnancy. Pharm Weekbl Sci 13(1):32-38
10. Egen V, Roesch C, Steinbicker V, Hasford J (2002) Drug utilization in Pregnancy-A Comparison between East and West Germany. Pharmacoepidemiol Drug Saf 11(Supp 1):148-149
11. Einerson A, Maltepe C, Novioz Y, Kennedy D, Tann MP, Koren G (2004) The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 111(9):940-943
12. Grospietsch G (2000) Erkrankungen in der Schwangerschaft: ein Leitfaden mit Therapie-empfehlungen für Klink und Praxis. Wiss Verl-Ges, Stuttgart
13. Hasford J (2002) Pegasus: Bayerischer Forschungsverbund Public Health (BFV), München
14. Hepner DL, Harnett MJ, Segal S, Camann W, Bader M, Tsen LC (2002) Herbal medicinal products during pregnancy: are they safe? Int J Obstet Gynecol 109:227-235
15. Homöopathisches Repetitorium (2003) Arzneimittellehre für die tägliche Praxis. Deutsche Homöopathie-Union, Karlsruhe
16. Jewell D, Young G (2004) Interventions for nausea and vomiting in early pregnancy (Cochrane Review). In: The cochrane library, Issue 2. Wiley, Chichester, UK
17. Kallen B, Mottet I (2003) Delivery outcome after the use of meclozine in early pregnancy. Eur J Epidemiol 18(7):665-669
18. Lacriox R, Eason E, Metzack R (2000) Nausea and vomiting during pregnancy. A prospective study of its frequency, intencity, and patterns of change. Am J Obstet Gynecol 182(4):931-937
19. Louik C, Hernandez-Diaz S, Werler MM, Mitchell AA (2004) Maternal factors associated with the use of herbal treatments in pregnancy. Pharmacoepidemiol Drug Saf 13(Suppl 1):241-242
20. Mielck A (2000) Soziale Ungleichheit und Gesundheit: Empirische Ergebnisse, Erklärungs-ansätze, Interventionsmöglichkeiten. Bern. Hans Huber-Verlag
21. Olsen C, Sonergaard C, Thrane N, Nielsen GL, van den Berg L, Olsen J (2001) For the EuorMAP group do pregnant women report use of dispensed medications? Epidemiology 12(5):497-501
22. Rote Liste® (2005)-Arzneimittelverzeichnis für Deutschland, Frankfurt/Main. Rote Liste® Service GmbH
23. Schwabe/Paffrath (ed) (2005) Arzneimittelverordnungs-Report 2005: Aktuelle Daten, Kosten, Trends und Kommentare. Springer, Berlin Heidelberg New York
24. Strunz-Lehner C, Egen-Lappe V, Hasford J, Janhsen K, Glaeske G (2004) The impact of region, age and social status on drug prescribing during pregnancy. Pharmacoepidemiol Drug Saf 13(Suppl 1):182
25. Therapeutic Goods Administration (The Australian Drug Evaluation Committee), Prescribing medicines in pregnancy (1999) An Australian categorisation of risk of drug use in pregnancy, 4th edn. Commenwelth of Australia, Australia
26. Weigel MM, Weigel RM (1988) The association of history, demographic factors, and alcohol and tobacco consumption with the risk of developing nausea and vomiting in early pregnancy. Am J Epidemiol 127:562-570